Carmignac Gestion Pfizer Inc Transaction History

Carmignac Gestion

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$39.39 - $51.28 $958,595 - $1.25 Million	-24,336 Reduced 34.54%	46,120 $1.88 Million
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $1.56 Million - $2.03 Million	37,312 Added 112.58%	70,456 $3.61 Million
Q3 2022 Nov 10, 2022	SELL	$43.76 - $53.42 $51 Million - $62.3 Million	-1,166,286 Reduced 97.24%	33,144 $1.45 Million
Q2 2022 Aug 12, 2022	SELL	$46.53 - $55.17 $67.4 Million - $79.9 Million	-1,447,517 Reduced 54.69%	1,199,430 $62.9 Million
Q1 2022 May 13, 2022	BUY	$45.75 - $56.69 $32.6 Million - $40.3 Million	711,627 Added 36.77%	2,646,947 $137 Million
Q4 2021 Feb 11, 2022	BUY	$41.32 - $61.25 $80 Million - $119 Million	1,935,320 New	1,935,320 $114 Million
Q4 2019 Feb 13, 2020	SELL	$32.92 - $37.36 $106 Million - $121 Million	-3,225,418 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$32.49 - $42.13 $105 Million - $136 Million	3,225,418 New	3,225,418 $116 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Carmignac Gestion, based on Form 13F filings with the SEC.

Stay updated on Carmignac Gestion with notifications on news.